Introduction of these cost-neutral items recognises that the procedure is a safe, non-invasive diagnostic tool and provides improved regulatory clarity by moving it from the Diagnostic Imaging Services Table to the General Medical Services Table. This change aligns funding with modern urological practice and improves patient access to necessary diagnostic care. Read more (PDF 217.9KB).